Filter by
Filter by
Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer
A study by the NCC, Korea group. This study retrospectively analyzed 42 patients with stage I NSCLC treated with protos to an initial dose of 60 CGE in 4...
High-dose conformal proton therapy for clinical perineural invasion in cutaneous head and neck cancer.
Perineural invasion (PNI) is an uncommon (<5%) which refers to tumor cell invasion extensive enough to cause clinically detectable deficits of the involved...
Hypofractionated Proton Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase I Trial From the University of Florida and Proton Collaborative Group.
Published in the Red Journal, this study reported the safety data from the first multicenter phase I trial investigating the use of hypofractionated proton...
Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Study.
22 patients with T1 to T2 N0M0 NSCLC received image-guided hypofractionated PBT to a total dose 48 GyRBE in 4 fractions for peripheral lesions and 60 GyRBE in...
Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.
This systematic review evaluated eight studies and 401 patients with early stage NSCLC treated with hypofractionated PBT to a median total dose of 63 Gy(RBE)...
Hypofractionation in Proton Therapy: radiobiological bases and clinical applications
The use of hypofractionated schedules in proton therapy is rapidly increasing. Their application has several advantages, including the reduction of overall...
Outcome after Radiotherapy for Vestibular Schwannomas – Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy.
Based on the data of 261 patients with VS treated with stereotactic radiosurgery/hypofractionated stereotactic radiotherapy (SRS/HFSRT), this study reported at...